Amgen buy out?

Discussion in 'Amgen' started by Anonymous, Jan 7, 2008 at 9:18 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    I heard today in ATO that Amgen is in talks with a company in regards to being bought out. Anyone else heard anything in regards to this?
     

  2. Anonymous

    Anonymous Guest

    not sure how good your source is, but a buy out has been in the speculation for weeks, if not months on open forums about amgen in the investment community. Given the weakness of $, it probably makes sense to have a buyer from Europe.
     
  3. Anonymous

    Anonymous Guest

    What do you think is for sale? A deep and productive pipeline? State of the art technology and scientist? A motiviated sales force? Great manufacturing capabilities? If you could answer yes to at least one of these questions, then someone will buy Amgen. No, Amgen will be dismantled by molecule to different buyers. Sort of like the 1990's when divesting was the way to maximize Management wealth, with a who gives a shit attitude for the workers and shareholders.
     
  4. Anonymous

    Anonymous Guest

    rumors come for the top...it is a good way to distract...very common tactic merck did it too....all lies... keeps everyone except a few looking the over way...same old same old....nothing changes at amgen....corruption at amgen has been discuss for a few years now..common folks....wake up??
     
  5. Anonymous

    Anonymous Guest

    Yes, the buyout rumors are actually fact. From a high-level source, i've been told that the new suitor is Sanofi-Aventis, one of the most healthy pharmaceutical firms looking to enrich their portfolio with biologics.
     
  6. Anonymous

    Anonymous Guest

    if they do buy will they dump all the useless upper management at Amgen that got us here to begin with?
     
  7. Anonymous

    Anonymous Guest


    please- not even a chance.. amgen is a mess morale...fraud...scandal...not cheap enough yet...lower?!?!?!
     
  8. Anonymous

    Anonymous Guest

    I am no Amgen glory monger but the pipeline is strong and Sanofi-Aventis? Please! They just hired the biggest idiot on the ATO campus! Talk about David and Goliath.

    I know enough to see the pipeline every day. I believe the buyout but not Sanofi. Pfizer, Lilly, Merck, GE anyone?
     
  9. Anonymous

    Anonymous Guest

    Rumors is rumors.

    Chicken little thought the sky was falling. But it wasn't

    Whats up with the NJ reps arbitration claim?
     
  10. Anonymous

    Anonymous Guest

    Anthera acquires rights to Amgen's lupus drug
    http://www.tradingmarkets.com/.site/news/Stock%20News/971768/

    It looks like we're just going to sell the company for parts! How sad.
     
  11. Anonymous

    Anonymous Guest

    Rumors are true. New owner to dump all the CP posters on day one. At least the half that actually work for Amgen and not pimping some agenda.
     
  12. Anonymous

    Anonymous Guest

    You were dead wrong.
     
  13. Anonymous

    Anonymous Guest

    Oh..Mr insider thanks for the crucial info.

    Dumbass amgen has $56 BL market cap plus another $17 bl in cash. There is NO company out there that has $80 billion to buy us for now. Pfizer jad that much money and tried hell in 2008 but could not succeed and ended up taking over wyeth. Thats pretty much about it.
     
  14. Anonymous

    Anonymous Guest

    Listen, if market cap is $56bn and AMgen has $17bn free cash than any buyer would not need $80bn to buy Amgen but only $40bn.
     
  15. Anonymous

    Anonymous Guest

    Good they need to dump alot of ARI management. Useless Vulgar pieces of crap....
     
  16. Anonymous

    Anonymous Guest

    good luck finding a job after leaving that dump the industry now of your back stabing ways .
     
  17. Anonymous

    Anonymous Guest

    Sanofi is busy buying small companies with a "hopeful" pipeline or ball powder companies. Amgen's price tag is not where they are focused. However, if you believe management is bad here....pray that Sanofi never takes over. The leadership there is a 'shit-for-brains' operation that is depending on employee lay-offs and miracle pipelines to survive.